| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |